Arsenic trioxide and tretinoin (AsO/ATRA) for Acute Promyelocytic Leukemia (APL)

Erin Damery, Dominic A. Solimando, James Waddell

Research output: Contribution to journalReview article

Abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

Original languageEnglish (US)
Pages (from-to)628-632
Number of pages5
JournalHospital Pharmacy
Volume51
Issue number8
DOIs
StatePublished - Sep 1 2016

Fingerprint

Acute Promyelocytic Leukemia
Poisons
Tretinoin
Pharmacists
Antineoplastic Agents
Drug Therapy
Chemotherapy
Neoplasms
Therapeutics
arsenic trioxide

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmacology (medical)

Cite this

Arsenic trioxide and tretinoin (AsO/ATRA) for Acute Promyelocytic Leukemia (APL). / Damery, Erin; Solimando, Dominic A.; Waddell, James.

In: Hospital Pharmacy, Vol. 51, No. 8, 01.09.2016, p. 628-632.

Research output: Contribution to journalReview article

Damery, Erin ; Solimando, Dominic A. ; Waddell, James. / Arsenic trioxide and tretinoin (AsO/ATRA) for Acute Promyelocytic Leukemia (APL). In: Hospital Pharmacy. 2016 ; Vol. 51, No. 8. pp. 628-632.
@article{e7879d349dc4494d88f89cdf3f7644e8,
title = "Arsenic trioxide and tretinoin (AsO/ATRA) for Acute Promyelocytic Leukemia (APL)",
abstract = "The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.",
author = "Erin Damery and Solimando, {Dominic A.} and James Waddell",
year = "2016",
month = "9",
day = "1",
doi = "10.1310/hpj5108-628",
language = "English (US)",
volume = "51",
pages = "628--632",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "8",

}

TY - JOUR

T1 - Arsenic trioxide and tretinoin (AsO/ATRA) for Acute Promyelocytic Leukemia (APL)

AU - Damery, Erin

AU - Solimando, Dominic A.

AU - Waddell, James

PY - 2016/9/1

Y1 - 2016/9/1

N2 - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

AB - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

UR - http://www.scopus.com/inward/record.url?scp=85020472638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020472638&partnerID=8YFLogxK

U2 - 10.1310/hpj5108-628

DO - 10.1310/hpj5108-628

M3 - Review article

AN - SCOPUS:85020472638

VL - 51

SP - 628

EP - 632

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 8

ER -